These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2685053)

  • 1. Evaluation of impact of immunocytochemical techniques in cytological diagnosis of neoplastic effusions.
    Linari A; Bussolati G
    J Clin Pathol; 1989 Nov; 42(11):1184-9. PubMed ID: 2685053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of HBME-1 immunostaining in serous effusions.
    Ascoli V; Carnovale-Scalzo C; Taccogna S; Nardi F
    Cytopathology; 1997 Oct; 8(5):328-35. PubMed ID: 9313985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive effusion cytology as the initial presentation of malignancy.
    Monte SA; Ehya H; Lang WR
    Acta Cytol; 1987; 31(4):448-52. PubMed ID: 3604540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytological differential diagnosis among adenocarcinoma, epithelial mesothelioma, and reactive mesothelial cells in serous effusions by immunocytochemistry.
    Su XY; Li GD; Liu WP; Xie B; Jiang YH
    Diagn Cytopathol; 2011 Dec; 39(12):900-8. PubMed ID: 20836004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytological diagnosis of serous effusions in a cancer hospital in Brazil.
    Oyafuso MS; Longatto Filho A; Bortolan J; Rahal P; Bisi H; Lombardo V
    Pathologica; 1996 Apr; 88(2):128-31. PubMed ID: 8927447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of a monoclonal antibody (B72.3) as an immunocytochemical adjunct to diagnosis of adenocarcinoma in human effusions.
    Johnston WW; Szpak CA; Lottich SC; Thor A; Schlom J
    Cancer Res; 1985 Apr; 45(4):1894-900. PubMed ID: 3884146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of cancer cells in effusions from patients diagnosed with gynaecological malignancies. Evaluation of five epithelial markers.
    Davidson B; Risberg B; Kristensen G; Kvalheim G; Emilsen E; Bjåmer A; Berner A
    Virchows Arch; 1999 Jul; 435(1):43-9. PubMed ID: 10431845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunocytochemistry in the differential diagnosis of serous effusions: a comparative evaluation of eight monoclonal antibodies in Papanicolaou stained smears.
    Lozano MD; Panizo A; Toledo GR; Sola JJ; Pardo-Mindán J
    Cancer; 2001 Feb; 93(1):68-72. PubMed ID: 11241268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytologic diagnosis of malignant mesothelioma in serous effusions using an antimesothelial-cell antibody.
    Donna A; Betta PG; Bellingeri D; Tallarida F; Pavesi M; Pastormerlo M
    Diagn Cytopathol; 1992; 8(4):361-5. PubMed ID: 1638937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunocytochemical staining of serous effusions with the monoclonal antibody Ber-EP4.
    De Angelis M; Buley ID; Heryet A; Gray W
    Cytopathology; 1992; 3(2):111-7. PubMed ID: 1617160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic accuracy of toluidine blue-stained wet films in effusion cytology.
    Erkiliç S; Koçer NE
    Acta Cytol; 2006; 50(4):407-9. PubMed ID: 16901004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunocytochemical characterization of lymphocytes in benign and malignant lymphocyte-rich serous effusions.
    Spieler P; Kradolfer D; Schmid U
    Virchows Arch A Pathol Anat Histopathol; 1986; 409(2):211-21. PubMed ID: 3087054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of immunocytochemistry in the study of malignant effusions.
    Mason MR; Bedrossian CW; Fahey CA
    Diagn Cytopathol; 1987 Sep; 3(3):215-21. PubMed ID: 3311665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic problems in serous effusions.
    Bedrossian CW
    Diagn Cytopathol; 1998 Aug; 19(2):131-7. PubMed ID: 9702493
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunocytochemical staining with monoclonal antibodies in cytologically "negative" serous effusions from patients with malignant disease.
    Ghosh AK; Mason DY; Spriggs AI
    J Clin Pathol; 1983 Oct; 36(10):1150-3. PubMed ID: 6194182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunocytochemical panel for distinguishing between carcinoma and reactive mesothelial cells in body cavity fluids.
    Politi E; Kandaraki C; Apostolopoulou C; Kyritsi T; Koutselini H
    Diagn Cytopathol; 2005 Mar; 32(3):151-5. PubMed ID: 15690338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of a pool of monoclonal antibodies in diagnosing cells from serous cavities.
    Cappellari A; Bagarella M; Ménard S; Calabrese M; Colnaghi MI
    Tumori; 1993 Jun; 79(3):211-3. PubMed ID: 8236507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of adenocarcinoma in cytospin preparations of effusions using monoclonal antibody B72.3.
    Martin SE; Moshiri S; Thor A; Vilasi V; Chu EW; Schlom J
    Am J Clin Pathol; 1986 Jul; 86(1):10-8. PubMed ID: 3524191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunofluorescent staining of metastatic carcinoma cells in serious fluid with carcinoembryonic antibody, epithelial membrane antibody, AUA-1 and Ber-EP4.
    Illingworth AL; Young JA; Johnson GD
    Cytopathology; 1994 Oct; 5(5):270-81. PubMed ID: 7819512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunocytochemical reaction of Ca1 and HMFG2 monoclonal antibodies with cells from serous effusions.
    Singer S; Boddington MM; Hudson EA
    J Clin Pathol; 1985 Feb; 38(2):180-4. PubMed ID: 3881482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.